627076-46-4 Usage
General Description
1-(2,3-difluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carbonitrile is a chemical compound with the molecular formula C16H9F2N5. It is a pyrazolo[3,4-b]pyridine derivative that contains a carbonitrile functional group. 1-(2,3-difluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carbonitrile has potential applications in the field of medicinal chemistry, particularly in the development of pharmaceutical drugs. Its unique molecular structure makes it a promising candidate for further study and research, as it may exhibit interesting biological and pharmacological properties. It is important for researchers to investigate the potential uses and effects of this compound in various applications, including drug discovery and development.
Check Digit Verification of cas no
The CAS Registry Mumber 627076-46-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,2,7,0,7 and 6 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 627076-46:
(8*6)+(7*2)+(6*7)+(5*0)+(4*7)+(3*6)+(2*4)+(1*6)=164
164 % 10 = 4
So 627076-46-4 is a valid CAS Registry Number.
627076-46-4Relevant articles and documents
RING-FUSED PYRIMIDINES AND TRIAZINES AND USE THEREOF FOR THE TREATMENT AND/OR PROPHYLAXIS OF CARDIOVASCULAR DISEASES
-
Paragraph 0433; 0434; 0435; 0436; 0527 - 0530, (2014/12/09)
The present application relates to novel fused pyrimidines and triazines, to processes for their preparation, to their use alone or in combinations for the treatment and/or prophylaxis of diseases and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of cardiovascular disorders.
Heterocyclic Substituted, Anellated Pyrazole Derivative and its uses
-
Page/Page column 18, (2010/02/16)
The present application relates to novel heterocyclyl-substituted fused pyrazole derivatives, to processes for their preparation, to their use, alone or in combination, for the treatment and/or prevention of diseases and to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of cardiovascular disorders.
